ClinConnect ClinConnect Logo
Search / Trial NCT07071298

AERA Pediatrics Registry

Launched by INTEGRA LIFESCIENCES CORPORATION · Jul 8, 2025

Trial Information

Current as of September 12, 2025

Recruiting

Keywords

Etbd

ClinConnect Summary

This clinical trial is studying how well the AERA® device works for children with problems related to the Eustachian tube, which is a small passage that helps equalize ear pressure and drain fluid. The study is collecting real-world information from multiple centers to see how the device performs in everyday use. It is currently open and looking for participants under the age of 18 who have a clear reason to try Eustachian tube balloon dilation (ETBD) using the AERA® device.

Children who have already had this procedure done with the AERA® device and meet the specific medical reasons for ETBD may be eligible to join. However, children who have had ETBD with a different device or have had the procedure before are not included. If your child participates, doctors will observe and record how the device works during their treatment without changing their usual care. This study helps gather important information to make sure this treatment is safe and effective for kids who need it.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age \<18
  • 2. Specific indications for ETBD are documented
  • 3. ETBD with AERA device attempted-
  • Exclusion Criteria:
  • 1. ETBD with device other than AERA®
  • 2. Previous ETBD procedure-

About Integra Lifesciences Corporation

Integra LifeSciences Corporation is a leading global medical technology company specializing in regenerative medicine and neurosurgery. With a commitment to innovation and excellence, Integra develops a diverse range of advanced technologies and products designed to improve patient outcomes in areas such as tissue regeneration, surgical reconstruction, and advanced wound care. The company is dedicated to supporting healthcare professionals through clinical trials that aim to validate the safety and efficacy of its cutting-edge solutions, ultimately enhancing the quality of care for patients worldwide. Integra’s focus on research and development, coupled with its robust portfolio, positions it as a key player in the medical device industry.

Locations

West Bloomfield, Michigan, United States

Fort Worth, Texas, United States

Patients applied

0 patients applied

Trial Officials

Christopher Schutt, MD

Study Director

Acclarent, an Integra LifeSciences Company

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported